Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients-Reference-Cited by-同舟云学术

Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients

Published:2021-06-03 Issue:10 Volume:106 Page:2754-2758
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Weinhold Niels,Salwender Hans J.,Cairns David A.,Raab Marc S.,Waldron George,Blau Igor W.,Bertsch Uta,Hielscher Thomas,Morgan Gareth J.,Jauch Anna,Davies Faith E.,Hänel Mathias,Cook Gordon,Scheid Christoph,Houlston Richard,Goldschmidt Hartmut,Jackson Graham,Kaiser Martin F.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma;2024-09-04

2. A predictive risk‐scoring model for survival prognosis of multiple myeloma based on gain/amplification of 1q21: Experience in a tertiary hospital in South‐Western China;Cancer Medicine;2024-09

3. Prognostic value of the “dynamic” R2‐ISS in patients with multiple myeloma undergoing anti‐CD38 antibody‐based triplet therapies;Hematological Oncology;2024-08-03

4. The impact of biomarkers of malignancy (IMWG SLiM criteria) in myeloma in a real‐world population: Clinical characteristics, therapy and outcomes from the Australian and New Zealand Myeloma and Related Diseases Registry (ANZ MRDR);British Journal of Haematology;2024-07-04

5. Diagnosis and initial treatment of transplant‐eligible high‐risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper;British Journal of Haematology;2024-07